HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Victor G Prieto Selected Research

Skin Neoplasms (Skin Cancer)

4/2012Merkel cell polyomavirus DNA detection in a patient with Merkel cell carcinoma and multiple other skin cancers.
4/2010Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
12/2005In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Victor G Prieto Research Topics

Disease

113Neoplasms (Cancer)
03/2024 - 02/2002
111Melanoma (Melanoma, Malignant)
09/2023 - 02/2002
25Neoplasm Metastasis (Metastasis)
03/2023 - 02/2002
18Nevus (Nevi)
01/2023 - 05/2003
16Carcinoma (Carcinomatosis)
02/2024 - 01/2006
15Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2021 - 03/2006
8Sarcoma (Soft Tissue Sarcoma)
11/2023 - 04/2003
7Pigmented Nevus (Melanocytic Nevus)
11/2021 - 01/2002
7Mycosis Fungoides
11/2019 - 04/2003
6Merkel Cell Carcinoma
09/2022 - 04/2007
5Breast Neoplasms (Breast Cancer)
03/2023 - 07/2009
5Dermatitis
10/2020 - 02/2017
5Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2017 - 04/2003
5Dysplastic Nevus Syndrome (Dysplastic Nevus)
03/2007 - 11/2003
4Bullous Pemphigoid (Pemphigoid)
07/2023 - 08/2016
4Cicatrix (Scar)
12/2022 - 08/2002
4Skin Diseases (Skin Disease)
03/2022 - 12/2012
4Lymphoma (Lymphomas)
05/2021 - 02/2007
4Lymphatic Metastasis
03/2016 - 03/2002
4Actinic Keratosis
07/2014 - 06/2008
4Keratoacanthoma
07/2014 - 06/2008
4Carcinogenesis
05/2010 - 04/2006
4Renal Cell Carcinoma (Grawitz Tumor)
04/2010 - 05/2007
3Blister (Bulla)
07/2023 - 08/2016
3Disease Progression
03/2023 - 01/2009
3Basal Cell Carcinoma (Rodent Ulcer)
01/2020 - 05/2008
3Inflammation (Inflammations)
11/2019 - 01/2009
3Keratosis
09/2019 - 02/2013
3Necrosis
01/2019 - 08/2004
3Hemangiosarcoma (Angiosarcoma)
06/2018 - 01/2013
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2018 - 01/2015
3Exanthema (Rash)
12/2017 - 01/2009
3Skin Neoplasms (Skin Cancer)
04/2012 - 12/2005
2Residual Neoplasm
09/2022 - 04/2010
2Hyperphosphatemia
03/2021 - 10/2018
2Hyperpigmentation
05/2020 - 12/2015
2Acrospiroma
08/2019 - 04/2010
2Fever (Fevers)
01/2019 - 12/2016
2Panniculitis
12/2017 - 08/2015

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
09/2023 - 10/2002
18Biomarkers (Surrogate Marker)IBA
11/2020 - 12/2006
15ParaffinIBA
11/2019 - 10/2002
13Formaldehyde (Formol)FDA Link
11/2019 - 10/2002
11Immune Checkpoint InhibitorsIBA
07/2023 - 01/2017
10AntigensIBA
01/2023 - 05/2007
9Imatinib Mesylate (Gleevec)FDA Link
04/2010 - 08/2002
7Keratins (Keratin)IBA
06/2023 - 03/2004
7Monoclonal AntibodiesIBA
01/2023 - 02/2004
7RNA (Ribonucleic Acid)IBA
04/2021 - 08/2004
7VemurafenibIBA
03/2016 - 12/2012
6pembrolizumabIBA
03/2023 - 08/2016
6DNA (Deoxyribonucleic Acid)IBA
11/2019 - 12/2009
5NivolumabIBA
03/2023 - 08/2016
5Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022 - 04/2003
5S100 Proteins (S 100 Protein)IBA
04/2021 - 05/2003
5Messenger RNA (mRNA)IBA
01/2021 - 10/2004
5dabrafenibIBA
09/2019 - 02/2013
5AntibodiesIBA
09/2019 - 01/2006
5LigandsIBA
05/2019 - 01/2006
5MART-1 AntigenIBA
08/2017 - 07/2009
5ErbB Receptors (EGF Receptor)IBA
03/2014 - 12/2004
4CTLA-4 AntigenIBA
07/2018 - 01/2017
4Transcription Factors (Transcription Factor)IBA
03/2018 - 12/2005
4Melanins (Melanin)IBA
08/2017 - 01/2002
4Sorafenib (BAY 43-9006)FDA Link
03/2014 - 06/2008
4Platelet-Derived Growth FactorIBA
06/2011 - 04/2006
3CollagenIBA
11/2023 - 01/2002
3Telomerase (Telomerase Reverse Transcriptase)IBA
09/2023 - 01/2021
3IpilimumabIBA
01/2021 - 01/2017
3Estrogen ReceptorsIBA
01/2021 - 10/2011
3CytokinesIBA
11/2019 - 05/2012
3Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 10/2004
3MicroRNAs (MicroRNA)IBA
11/2018 - 06/2013
3Monophenol Monooxygenase (Tyrosinase)IBA
09/2017 - 06/2014
3Indicators and Reagents (Reagents)IBA
11/2016 - 01/2011
3Carcinoembryonic AntigenIBA
06/2014 - 05/2009
3Mucin-1 (CA 15-3 Antigen)IBA
06/2014 - 10/2007
3Hormones (Hormone)IBA
01/2014 - 08/2004
3Androgen Receptors (Androgen Receptor)IBA
01/2014 - 09/2005
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
04/2007 - 01/2003
2Myosins (Myosin)IBA
03/2024 - 05/2008
2SynaptophysinIBA
06/2023 - 04/2007
2relatlimabIBA
03/2023 - 11/2022
2Coloring Agents (Dyes)IBA
09/2022 - 02/2014
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 08/2004
2Cyclin D1IBA
04/2021 - 04/2016
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2020 - 02/2017
2Paclitaxel (Taxol)FDA LinkGeneric
06/2018 - 03/2016
2Brentuximab VedotinIBA
05/2018 - 12/2016
2Eosine Yellowish-(YS) (Eosin)IBA
01/2018 - 05/2009
2Hematoxylin (Haematoxylon)IBA
01/2018 - 05/2009
2VimentinIBA
08/2017 - 10/2013

Therapy/Procedure

74Therapeutics
01/2024 - 02/2002
10Drug Therapy (Chemotherapy)
09/2022 - 10/2004
9Aftercare (After-Treatment)
01/2021 - 08/2002
8Immunotherapy
03/2023 - 08/2016
8Radiotherapy
01/2016 - 03/2002
7Lymph Node Excision (Lymph Node Dissection)
12/2019 - 07/2002
3Neoadjuvant Therapy
03/2023 - 07/2018
2Debridement
01/2019 - 10/2004